The use of systemic corticosteroids appears not to benefit patients with non-arteritic anterior ischemic optic neuropathy (NAION), according to new data reported at the NANOS conference.
The use of systemic corticosteroids appears not to benefit patients with non-arteritic anterior ischemic optic neuropathy (NAION), according to new data reported at the NANOS conference.